Showing results (2031-2040 of 2,436) with videos related to

Sort By:
Pageof 244
Clinical Genitourinary Cancer|August 1, 2020
Correlation Between Immune-related Adverse Event (IRAE) Occurrence and Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Nivolumab: IRAENE Trial, an Italian Multi-institutional Retrospective StudyMaria Giuseppa Vitale, Stefania Pipitone, Marta Venturelli, et al.
Clinical & Experimental Metastasis|February 16, 2024
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinationsMichele Maffezzoli, Matteo Santoni, Giulia Mazzaschi, et al.
The Journal of Urology|November 30, 2014
Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinomaRoberto Iacovelli, Alessio Farcomeni, Cora N Sternberg, et al.
Cancer Medicine|February 21, 2025
Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective ExperienceMimma Rizzo, Franco Morelli, Yüksel Ürün, et al.
Targeted Oncology|August 6, 2024
Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 ProjectAlessandro Rizzo, Fernando Sabino Marques Monteiro, Yüksel Ürün, et al.
ESMO Open|July 6, 2026
Real-world prognostic assessment of the HERO score in metastatic urothelial carcinoma treated with enfortumab vedotin (ARON-2EV study)G Roviello, F Ciccimarra, F Urabe, et al.
Annals of Botany|June 27, 2015
Genetic structure of the date palm (Phoenix dactylifera) in the Old World reveals a strong differentiation between eastern and western populationsSalwa Zehdi-Azouzi, Emira Cherif, Souhila Moussouni, et al.
European Urology Oncology|June 3, 2025
Real-World Outcomes and Molecular Profiling for Patients with Metastatic Castration-resistant Prostate Cancer with Lung Metastases: A Long-term Multicenter ExperienceGiuseppina Bruno, Maria Iole Natalicchio, Marianna Garofoli, et al.
JCO Global Oncology|July 8, 2025
Geographical Differences in the Management and Outcomes of Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab After Progression on Platinum-Based Chemotherapy: Results From ARON-2 StudyMimma Rizzo, Andrey Soares, Shilpa Gupta, et al.
Science Advances|April 13, 2022
When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancerMohamed S Hasim, Marie Marotel, Jonathan J Hodgins, et al.
Pageof 244